Either you have JavaScript disabled or your browser does not support Javascript . To work properly, this page requires JavaScript to be enabled.
How to enable JavaScript in your browser?

A Randomized, Open-label, Four-Way Crossover Study to Compare the Bioavailability of a Single Dose of Epanova or Lovaza After a Low-Fat and High-Fat Meal.

Trial Profile

A Randomized, Open-label, Four-Way Crossover Study to Compare the Bioavailability of a Single Dose of Epanova or Lovaza After a Low-Fat and High-Fat Meal.

Status: Completed
Phase of Trial: Phase II

Latest Information Update: 22 Jul 2015

Price : $35 *
  • Adis is an information provider.
  • Final gross price and currency may vary according to local VAT and billing address.
  • Your purchase entitles you to full access to the information contained in our trial profile at the time of purchase.
  • A link to download a PDF version of the trial profile will be included in your email receipt.

At a glance

  • Drugs Omega-3 carboxylic acids (Primary) ; Omega-3-acid ethyl esters
  • Indications Crohn's disease; Hypertriglyceridaemia
  • Focus Pharmacokinetics
  • Acronyms ECLIPSE
  • Most Recent Events

    • 10 Jan 2012 Long-term (2-week) bioavailability data were presented at the J.P. Morgan Healthcare Conference.
    • 16 Nov 2011 Results presented at the 84th Annual Scientific Sessions of the American Heart Association.
    • 17 May 2011 Trial phase changed from I/II to II as reported by ClinicalTrials.gov.
Subscriber content

You need to be a logged in subscriber to view this content.

If your organization has a subscription then there are several options available to help you access AdisInsight, even while working remotely.

  • IP authentication when working within your organization’s network.
  • with username/password or try via your institution
  • Persisted access using your organization’s identifier stored in your user browser for 90 days.
  • Contact us at AsktheExpert.AdisInsight@springer.com for assistance.

If your organization does not have a subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Buy a PDF version of the profile.
  • Request a free trial
Back to top